# Amboy Street Ventures

> Amboy Street Ventures is a VC fund backing Health Care and Women's. See 19 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Los Angeles, United States
- Total investments: 19
- Last investment: Nov 2025
- Lead investor: 11%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/47651749
- Website: https://www.amboystreet.vc/

Amboy Street Ventures is a VC fund in Los Angeles focused on Health Care and Women's. Amboy Street Ventures focuses on sexual health and women’s health technology startups. Amboy Street Ventures was founded in 2021 and was headquartered in Los Angeles, USA.

## Contacts

5 contacts available for Amboy Street Ventures. Shizune tracks 3 team members at Amboy Street Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/amboy-street-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 47% |
| Women's | 5 | 26% |
| Wellness | 5 | 26% |
| Biotechnology | 4 | 21% |
| Medical | 2 | 11% |

25 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 9 | 47% |
| Seed | 5 | 26% |
| Pre-Seed | 1 | 5% |
| Series B | 1 | 5% |
| Venture - Series Unknown | 1 | 5% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 13 | 68% |
| Canada | 1 | 5% |
| Sweden | 1 | 5% |
| Switzerland | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Adele Rom | Investor | 0 | https://shizune.co/investors/profile/adele-rom-a8d7 |
| Dominnique Karetsos | General Partner | 0 | https://shizune.co/investors/profile/dominnique-karetsos-632f |
| Maria Fernanda Peraza Godoy | General Partner | 0 | https://shizune.co/investors/profile/maria-fernanda-peraza-godoy |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nest Health | Nest Health offers medical services that aim to minimize the stress of arranging childcare, making travel arrangements, and leaving home. The company offers a wide range of services to newborns, babies, children, teens, and adults for medical, behavioral, nutrition, and more, enabling patients to get treated at home. | $10M | Series A | Nov 21, 2025 |  |
| Allswell | Allswell is a community-first mental health care provider that provides virtual mental health therapy services for queer adults. The company connects clients with licensed therapists who are trained in LGBTQ+-affirming care and offer both one-on-one and peer group therapy sessions. Its services address a range of needs, including identityexploration, trauma recovery, relationship challenges, and stress related to discrimination or marginalization.Clients can start with a free 15-minute consultation, followed by an intake session where a personalized care plan is developed. Allswell’s therapy sessions are conducted via secure video calls, and clients can choose weekly individual or group meetings. The platform accepts Medicaid in Maryland and major commercial insurance plans, while self-pay clients are offered discounted introductory sessions. Through its approach, Allswell aims to make accessible, culturally competent mental health care available to queer individuals in a supportive virtual environment. | $1.3M | Pre-Seed | Oct 29, 2025 |  |
| Nest Health | Nest Health offers medical services that aim to minimize the stress of arranging childcare, making travel arrangements, and leaving home. The company offers a wide range of services to newborns, babies, children, teens, and adults for medical, behavioral, nutrition, and more, enabling patients to get treated at home. | $12.5M | Series A | Aug 25, 2025 |  |
| Juniper Genomics | Juniper Genomics brings modern genomics and data science to those trying to conceive to help overcome barriers and challenges facing IVF patients. | $4.6M | Seed | Jun 26, 2025 |  |
| Gesynta Pharma | Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se | $27.6M | Series B | Jan 20, 2025 |  |
| Granata Bio | Granata Bio is a biotechnology focused on identifying and developing therapeutics for fertility patients. Founded in 2018, the Company recently announced a partnership with IBSA Institut Biochimique (Lugano CH) to co-develop a novel subcutaneous progesterone solution. | $15M | Series A | Jan 15, 2025 |  |
| Alloy | Alloy is a telehealth company addressing the healthcare needs of women over 40. | $16M | Series A | Nov 18, 2024 |  |
| Testmate Health | Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home. | $6M | Seed | May 02, 2024 |  |
| Granata Bio | Granata Bio is a biotechnology focused on identifying and developing therapeutics for fertility patients. Founded in 2018, the Company recently announced a partnership with IBSA Institut Biochimique (Lugano CH) to co-develop a novel subcutaneous progesterone solution. | $14M | Series A | Jan 16, 2024 |  |
| Evvy | Evvy is a developer of at-home vaginal microbiome tests to close the gender health gap and improve female health. It uses metagenomic sequencing to understand symptoms and risks for critical health challenges, and get personalized reports. | $14M | Series A | Sep 27, 2023 |  |

10 of 19 investments shown.

## Co-investors
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 4 deals together
- [Flybridge](https://shizune.co/investors/profile/flybridge-capital) — VC Fund, 3 deals together
- [RH Capital](https://shizune.co/investors/profile/rh-capital) — VC Fund, 3 deals together
- [8VC](https://shizune.co/investors/profile/8vc) — VC Fund, 2 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 2 deals together
- [CooperSurgical](https://shizune.co/investors/profile/coopersurgical-inc) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund

## Featured in investor lists
- [Life Science Investors in Switzerland](https://shizune.co/investors/life-science-investors-switzerland)

## FAQ

### What does Amboy Street Ventures invest in?

Amboy Street Ventures invests primarily in Health Care, Women's and Wellness startups, most often at Series A and Seed stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Amboy Street Ventures?

Public channels for Amboy Street Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Amboy Street Ventures?

The team at Amboy Street Ventures includes Adele Rom (Investor), Dominnique Karetsos (General Partner) and Maria Fernanda Peraza Godoy (General Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co